AI Article Synopsis
- Epilepsy affects nearly 1% of the population, making it one of the most common neurological disorders, but significant gaps remain in understanding its incidence, prevalence, and treatment success.
- Many of these gaps exist because the pharmaceutical industry is not focused on conducting adequate studies related to epilepsy.
- An online knowledge management database has been developed to provide information on epilepsy medications and side effects, potentially serving as a model for similar initiatives in other medical areas.
Article Abstract
With an incidence of nearly 1%, epilepsy represents one of the most frequent diseases in the population. Nevertheless substantial information gaps exist as to the exact incidence, prevalence, therapy and particularly to associated therapeutic success. Adequate studies are not performed on many of these issues which are primarily beyond the current interests of the pharmaceutical industry. An Internet-based knowledge management database is presented to illustrate initial results of the online system with a focus on medication and side effects (http://www.ligaepilepsie.org/KnowledgeDB/index.htm). Further, it is worth noting that this database was designed as a potential model for similar projects in other medical fields.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.seizure.2007.06.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!